AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2020

Aug 25, 2020

29819_dirs_2020-08-25_f542fa7d-6bf5-4be1-95fa-a0672eb11cc4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2020-08-25

Reporting Person: AMGEN INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-25	American Depositary Shares	A	59390	$248.4859	Acquired	18524373	Direct

Footnotes

F1: This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.

F2: The price reported is an average price. These American Depositary Shares ("ADSs") were purchased at prices ranging from $238.13 to $254.57 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F3: As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 240,816,849 Ordinary Shares.